1. "Sloan Kettering Institute Postdocs"
Formats
  1. Journal Article (7820)
  2. Meeting Abstract (3612)
  3. Review (610)
  4. Editorial (251)
  5. Book Section (189)
  6. Conference Paper (160)
  7. Research Letter (133)
  8. Correspondence (63)
  9. Miscellaneous (62)
  10. Guidelines (30)
  11. Book Whole (6)
Groups
  1. Sloan Kettering Institute Postdocs (12936)
  2. GSK Faculty (6210)
  3. Department of Medicine (4656)
  4. Sloan Kettering Institute Faculty (3490)
  5. Surgery (2557)
  6. Solid Tumor Oncology Division (2525)

More Groups

People
  1. Britta Weigelt (366)
  2. Jorge Reis-Filho (327)
  3. Mithat Gonen (309)
  4. Marc Ladanyi (304)
  5. Joseph Deasy (278)
  6. Michael Berger (278)

More People

Years
  1. 2025 (394)
  2. 2024 (1038)
  3. 2023 (1151)
  4. 2022 (1364)
  5. 2021 (1176)
  6. 2020 (1240)

More Years

Publications
  1. Blood (641)
  2. Cancer Research (542)
  3. Journal of Clinical Oncology (416)
  4. Journal of Nuclear Medicine (261)
  5. Annals of Surgical Oncology (257)
  6. Clinical Cancer Research (235)

More Publications

Publishers
  1. Nature Publishing Group (1308)
  2. Elsevier Inc. (1173)
  3. American Association for Cancer Research (1039)
  4. Springer (818)
  5. Cell Press (719)
  6. American Society of Hematology (697)

More Publishers

Results (12936)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Combination therapy using JAK2 and HSP90 inhibitors increased efficacy in myelofibrosis in vivo
    Meeting Abstract

    Levine, R. L.; Koppikar, P.; Marubayashi, S.; Bhagwat, N.; Taldone, T.; Park, C. Y.; Chiosis, G.
    Blood (2012)

    Fulltext@MSK | Save
  • CD19-targeted donor T cells exert potent graft versus lymphoma activity and attenuated GVHD
    Meeting Abstract

    Ghosh, A.; Davila, M. L.; Young, L. F.; Kloss, C.; Gunset, G.; Smith, O. M.; West, M. L.; Singer, N. V.; Holland, A. M.; Jenq, R. R.; more...
    Blood (2012)

    Fulltext@MSK | Save
  • IPS cells from Del(7q)-MDS patients display impaired proliferation and hematopoietic commitment
    Meeting Abstract

    Boussaad, I.; Dolezal, E. K.; Perna, F.; Nimer, S. D.; Papapetrou, E. P.
    Blood (2012)

    Fulltext@MSK | Save
  • Conditional deletion of asxl1 results in myelodysplasia
    Meeting Abstract

    Abdel-Wahab, O.; Gao, J.; Adli, M.; Chung, Y. R.; Koche, R.; Shih, A. H.; Pandey, S.; LaFave, L. M.; Ndiaye-Lobry, D.; Shin, Y. S.; more...
    Blood (2012)

    Fulltext@MSK | Save
  • BAY80-6946 is a potent and selective PI3K inhibitor that induces apoptosis in breast cancers by blocking AKT and non-AKT PI3K effector pathways
    Meeting Abstract

    Will, M.; Toy, W.; Patel, P.; Rodrik-Outmezguine, V.; Schneider, C.; Paul, J.; Liu, N.; Rosen, N.; Chandarlapaty, S.
    European Journal of Cancer (2012)

    Fulltext@MSK | Save
  • A mechanistic logic for dual targeting of HER2 and PI3K/AKT/mTOR signaling in HER2 amplified breast cancer
    Meeting Abstract

    Chandarlapaty, S.; Rodrik-Outmezguine, V.; Scaltriti, M. M.; Sakr, R.; Will, M.; Giri, D.; Hudis, C.; Baselga, J.; King, T.; Rosen, N.
    European Journal of Cancer (2012)

    Fulltext@MSK | Save
  • Effects of radiologic tumor response of anti-glypican-3 GC33 and multi tyrosine kinases inhibitor sorafenib in hepatocellular carcinoma
    Meeting Abstract

    Abou-Alfa, G. K.; Zhao, B.; Chou, J. F.; Ma, J.; Capanu, M.; Koga, M.; Lee, R.; Othomo, T.; Germino, J.; Schwartz, L.
    European Journal of Cancer (2012)

    Fulltext@MSK | Save
  • (124)I GC33 positron emission tomography (PET), imaging biomarker of glypican-3 in hepatocellular carcinoma
    Meeting Abstract

    Abou-Alfa, G. K.; O'Donoghue, J. A.; Gansukh, B.; Ma, J.; Ruan, S.; Koga, M.; Lee, R.; Ohishi, N.; Othomo, T.; Carrasquillo, J. A.
    European Journal of Cancer (2012)

    Fulltext@MSK | Save
  • Whole exome sequencing identifies ATRX mutation as a key molecular determinant in lower-grade glioma
    Journal Article

    Kannan, K.; Inagaki, A.; Silber, J.; Gorovets, D.; Zhang, J.; Kastenhuber, E. R.; Heguy, A.; Petrini, J. H.; Chan, T. A.; Huse, J. T.
    Oncotarget (2012)

    Fulltext@MSK | Save
  • A nonrandomized, phase II study of sequential irinotecan and flavopiridol in patients with advanced hepatocellular carcinoma
    Journal Article

    Ang, C.; O'Reilly, E. M.; Carvajal, R. D.; Capanu, M.; Gonen, M.; Doyle, L.; Ghossein, R.; Schwartz, L.; Jacobs, G.; Ma, J.; more...
    Gastrointestinal Cancer Research (2012)

    Fulltext@MSK | Save